Effects of intravitreal administration of steroids on experimental subretinal neovascularization in the subhuman primate

T. Ishibashi, K. Miki, N. Sorgente, R. Patterson and S. J. Ryan

To elucidate the role of inflammation in the occurrence of experimental subretinal neovascularization caused by high-intensity laser photocoagulation, we investigated the effects of vitreal infusion of steroids on laser lesions in a primate model. Dexamethasone, with or without triamcinolone, was infused continuously for two weeks through an indwelling cannula system. The animals were followed up clinically for up to eight weeks. The frequency of subretinal neovascularization in the steroid-treated animals was significantly lower than that in a control group of untreated animals. Although steroids have multiple effects, these results suggest that the inflammatory response, possibly macrophage infiltration, may plan an important role in the occurrence of subretinal neovascularization in our experimental model.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Early Effects of Triamcinolone on Vascular Endothelial Growth Factor and Endostatin in Human Choroidal Neovascularization
Tatar et al.
Arch Ophthalmol 2008;126:193-199.
ABSTRACT | FULL TEXT  

Positive Feedback Regulation between MMP-9 and VEGF in Human RPE Cells
Hollborn et al.
IOVS 2007;48:4360-4367.
ABSTRACT | FULL TEXT  

Intravitreal Infliximab and Choroidal Neovascularization in an Animal Model
Olson et al.
Arch Ophthalmol 2007;125:1221-1224.
ABSTRACT | FULL TEXT  

Dexamethasone Inhibits Interleukin-1{beta}-Induced Corneal Neovascularization: Role of Nuclear Factor-{kappa}B-Activated Stromal Cells in Inflammatory Angiogenesis
Nakao et al.
Am. J. Pathol. 2007;171:1058-1065.
ABSTRACT | FULL TEXT  

Association between Circulating White Blood Cell Count and Long-Term Incidence of Age-related Macular Degeneration: The Blue Mountains Eye Study
Shankar et al.
Am J Epidemiol 2007;165:375-382.
ABSTRACT | FULL TEXT  

Combined photodynamic therapy and intravitreal triamcinolone injection for the treatment of choroidal neovascularisation secondary to pathological myopia: a pilot study
Chan et al.
Br. J. Ophthalmol. 2007;91:174-179.
ABSTRACT | FULL TEXT  

Should corticosteroids be considered as part of the standard care with photodynamic therapy?
Zarbin
Arch Ophthalmol 2006;124:563-571.
FULL TEXT  

Combined photodynamic therapy and intravitreal triamcinolone injection for the treatment of subfoveal choroidal neovascularisation in age related macular degeneration: a comparative study.
Chan et al.
Br. J. Ophthalmol. 2006;90:337-341.
ABSTRACT | FULL TEXT  

Choroidal neovascularisation in pathological myopia: an update in management
Chan et al.
Br. J. Ophthalmol. 2005;89:1522-1528.
ABSTRACT | FULL TEXT  

Effect of triamcinolone acetonide on proliferation of retinal endothelial cells in vitro and in vivo
Spandau et al.
Br. J. Ophthalmol. 2005;89:745-747.
ABSTRACT | FULL TEXT  

Factors influencing visual acuity after intravitreal triamcinolone acetonide as treatment of exudative age related macular degeneration
Jonas et al.
Br. J. Ophthalmol. 2004;88:1557-1562.
ABSTRACT | FULL TEXT  

Current Concepts in the Pathogenesis of Age-Related Macular Degeneration
Zarbin
Arch Ophthalmol 2004;122:598-614.
ABSTRACT | FULL TEXT  

Sorsby fundus dystrophy presenting with choroidal neovascularisation showing good response to steroid treatment
Atan et al.
Br. J. Ophthalmol. 2004;88:440-441.
FULL TEXT  

The Squirrel Monkey: Characterization of a New-World Primate Model of Experimental Choroidal Neovascularization and Comparison with the Macaque
Criswell et al.
IOVS 2004;45:625-634.
ABSTRACT | FULL TEXT  

Macrophage Depletion Diminishes Lesion Size and Severity in Experimental Choroidal Neovascularization
Espinosa-Heidmann et al.
IOVS 2003;44:3586-3592.
ABSTRACT | FULL TEXT  

Combretastatin A-4 Phosphate Suppresses Development and Induces Regression of Choroidal Neovascularization
Nambu et al.
IOVS 2003;44:3650-3655.
ABSTRACT | FULL TEXT  

Pseudo-endophthalmitis after intravitreal injection of triamcinolone
Sutter and Gillies
Br. J. Ophthalmol. 2003;87:972-974.
ABSTRACT | FULL TEXT  

Choroidal neovascular membrane inhibition in a laser treated rat model with intraocular sustained release triamcinolone acetonide microimplants
Ciulla et al.
Br. J. Ophthalmol. 2003;87:1032-1037.
ABSTRACT | FULL TEXT  

A Randomized Clinical Trial of a Single Dose of Intravitreal Triamcinolone Acetonide for Neovascular Age-Related Macular Degeneration: One-Year Results
Gillies et al.
Arch Ophthalmol 2003;121:667-673.
ABSTRACT | FULL TEXT  

Intravitreal triamcinolone acetonide for exudative age related macular degeneration
Jonas et al.
Br. J. Ophthalmol. 2003;87:462-468.
ABSTRACT | FULL TEXT  

AAV-Mediated Expression of Vascular Endothelial Growth Factor Induces Choroidal Neovascularization in Rat
Wang et al.
IOVS 2003;44:781-790.
ABSTRACT | FULL TEXT  

Intraocular pressure after intravitreal injection of triamcinolone acetonide
Jonas et al.
Br. J. Ophthalmol. 2003;87:24-27.
ABSTRACT | FULL TEXT  

Modulation of Permeability and Adhesion Molecule Expression by Human Choroidal Endothelial Cells
Penfold et al.
IOVS 2002;43:3125-3130.
ABSTRACT | FULL TEXT  

Intravitreal triamcinolone in recurrence of choroidal neovascularisation
Penfold
Br. J. Ophthalmol. 2002;86:600-601.
FULL TEXT  

Intravitreal Triamcinolone Acetonide Inhibits Choroidal Neovascularization in a Laser-Treated Rat Model
Ciulla et al.
Arch Ophthalmol 2001;119:399-404.
ABSTRACT | FULL TEXT  

Squalamine Improves Retinal Neovascularization
Higgins et al.
IOVS 2000;41:1507-1512.
ABSTRACT | FULL TEXT  

Targeted Disruption of the FGF2 Gene Does Not Prevent Choroidal Neovascularization in a Murine Model
Tobe et al.
Am. J. Pathol. 1998;153:1641-1646.
ABSTRACT | FULL TEXT  

Antenatal Dexamethasone and Decreased Severity of Retinopathy of Prematurity
Higgins et al.
Arch Ophthalmol 1998;116:601-605.
ABSTRACT | FULL TEXT